This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zidovetzki, R. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Zidovetzki, R. Articles by Faraci, F. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NICOTINE NICOTINE TARTRATE Related Collections Acute Stroke Syndromes Risk Factors for Stroke Thrombolysis

(Stroke. 1999;30:651-655.)
© 1999 American Heart Association, Inc.

Original Contributions

Nicotine Increases Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C–Associated Pathway

Raphael Zidovetzki, PhD; Peijia Chen, MD; Mark Fisher, MD Florence M. Hofman, PhD

From the Departments of Biology and Neuroscience, University of California, Riverside, Calif (R.Z.), and the Departments of Pathology (P.C., F.M.H.) and Neurology (M.F.), University of Southern California School of Medicine, Los Angeles, Calif.

Correspondence to Dr Florence Hofman, Department of Pathology, University of Southern California School of Medicine, 2011 Zonal Ave, Los Angeles, CA 90033. E-mail hofman{at}hsc.usc.edu

Background and Purpose—Smoking both increases stroke risk and reduces the risk of thrombolysis-associated intracerebral hemorrhage. Plasminogen activator inhibitor-1 (PAI-1) is a major regulator of fibrinolysis; elevation of PAI-1 is associated with an increased risk of thrombotic disorders. We studied the effect of nicotine, an important constituent of cigarette smoke, on PAI-1 production by human brain endothelial cells.

Methods—Adult human central nervous system endothelial cells (CNS-EC) were used for tissue culture experiments. We analyzed culture supernatant for PAI-1 protein and measured PAI-1 mRNA (by Northern blot analysis) and protein kinase C (PK-C) activity.

Results—Nicotine at 100 nmol/L increased PAI-1 protein production and mRNA expression by CNS-EC. After 72 hours of exposure to nicotine, the concentration of secreted PAI-1 in the cell supernatant was increased 1.90±0.2 fold compared with untreated cells. PAI-1 mRNA also increased approximately twofold. Inhibition of PK-C completely abolished this effect. Nicotine had no effect on the concentration of tissue plasminogen activator.

Conclusions—Nicotine increases brain endothelial cell PAI-1 mRNA expression and protein production via PK-C–dependent pathway. These findings provide new insights into why smoking may be associated with predisposition to thrombosis and inversely associated with intracerebral hemorrhage after therapeutic tissue plasminogen activator therapy.

Editorial Comment

Frank M. Faraci, PhD, Guest Editor

Department of Internal Medicine, Cardiovascular Center, University of Iowa College of Medicine, Iowa City, Iowa

This article has been cited by other articles:

				T. Raupach, K. Schafer, S. Konstantinides, and S. Andreas Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm Eur. Heart J., February 2, 2006; 27(4): 386 - 392. [Abstract] [Full Text] [PDF]

				O. Saijonmaa, T. Nyman, and F. Fyhrquist Regulation of angiotensin-converting enzyme production by nicotine in human endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2000 - H2004. [Abstract] [Full Text] [PDF]

				B. Ovbiagele and J. L. Saver The smoking-thrombolysis paradox and acute ischemic stroke Neurology, July 26, 2005; 65(2): 293 - 295. [Abstract] [Full Text] [PDF]

				V. F. Tapson The Role of Smoking in Coagulation and Thromboembolism in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 71 - 77. [Abstract] [Full Text] [PDF]

				A. I. Chernyavsky, J. Arredondo, L. M. Marubio, and S. A. Grando Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes J. Cell Sci., November 1, 2004; 117(23): 5665 - 5679. [Abstract] [Full Text] [PDF]

				M.P. Pellegrini, D. E Newby, S. Maxwell, and D. J Webb Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man Cardiovasc Res, November 1, 2001; 52(2): 321 - 327. [Abstract] [Full Text] [PDF]

				S. A. Mayer, J. Y. Chong, E. Ridgway, K. C. Min, C. Commichau, and G. L. Bernardini Delirium from nicotine withdrawal in neuro-ICU patients Neurology, August 14, 2001; 57(3): 551 - 553. [Abstract] [Full Text] [PDF]

				S. ZHANG, I. N. M. DAY, and S. YE Microarray analysis of nicotine-induced changes in gene expression in endothelial cells Physiol Genomics, April 27, 2001; 5(4): 187 - 192. [Abstract] [Full Text] [PDF]